Pica Press, Sussex, England
In that time, Ive watched the clinical culture around GLP-1s split in two directions
Food and Drug Administration (FDA) - "Saxenda (Liraglutide) Injection, for Subcutaneous Use." Accessed on April 3, 2024, at FDA - "Drug Compounding and Drug Shortages." Accessed on April 3, 2024, at Harvard T.H
And depending on your situation, Willow might not even require an in-person telehealth visit - most ladies can get stated with a few messages back and forth via the HipAA compliant Willow patient portal
A peer-reviewed study published in JMIR Formative Research in 2025 found that active subscribers on Second Natures GLP-1-supported programme lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving at least 10% weight loss